HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lei Feng Selected Research

dehydrocostus lactone

1/2021Erratum: Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-κB/COX-2 signaling pathway by targeting IKKβ.
1/2017Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-κB/COX-2 signaling pathway by targeting IKKβ.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lei Feng Research Topics

Disease

125Neoplasms (Cancer)
01/2024 - 05/2003
30Cognitive Dysfunction
01/2023 - 07/2008
28Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 05/2003
21Inflammation (Inflammations)
05/2024 - 05/2013
21Neoplasm Metastasis (Metastasis)
10/2023 - 05/2003
20Infections
03/2024 - 07/2005
18Stroke (Strokes)
10/2023 - 07/2012
16Hypertension (High Blood Pressure)
01/2024 - 01/2009
16Breast Neoplasms (Breast Cancer)
09/2023 - 03/2006
16Ischemic Stroke
01/2023 - 12/2010
15Carcinogenesis
10/2023 - 03/2004
15Pain (Aches)
08/2023 - 01/2013
15Lung Neoplasms (Lung Cancer)
01/2020 - 12/2006
14B-Cell Lymphoma (Lymphoma, B Cell)
11/2023 - 10/2014
13Lymphoma (Lymphomas)
11/2023 - 07/2005
13Multiple Myeloma
01/2022 - 12/2018
12Major Depressive Disorder (Major Depressive Disorders)
01/2024 - 01/2019
12Squamous Cell Carcinoma of Head and Neck
04/2022 - 07/2002
11Hepatocellular Carcinoma (Hepatoma)
01/2024 - 04/2005
11Hemorrhage
06/2023 - 01/2011
10Thrombosis (Thrombus)
10/2023 - 03/2009
10Myocardial Infarction
10/2023 - 09/2015
10Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 05/2012
9Coronary Artery Disease (Coronary Atherosclerosis)
10/2023 - 01/2019
9Dementia (Dementias)
01/2023 - 01/2017
9Disease Progression
01/2020 - 06/2006
9Mouth Neoplasms (Oral Cancer)
01/2018 - 01/2008
8Carcinoma (Carcinomatosis)
10/2023 - 10/2005
8Alzheimer Disease (Alzheimer's Disease)
01/2023 - 12/2019
8Pathologic Constriction (Stenosis)
01/2023 - 01/2009
7Hypoxia (Hypoxemia)
04/2024 - 12/2015
7Hodgkin Disease (Hodgkin's Disease)
12/2023 - 05/2012
7Esophageal Squamous Cell Carcinoma
12/2023 - 01/2018
7Necrosis
03/2023 - 03/2006
7Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 06/2010
6Uveitis
05/2024 - 09/2014
6Amblyopia (Lazy Eye)
04/2024 - 04/2012
6Neuroinflammatory Diseases
02/2024 - 10/2019
6Hyperlipidemias (Hyperlipidemia)
01/2024 - 01/2009
6Ischemia
01/2024 - 01/2015
6Acute Kidney Injury (Acute Renal Failure)
06/2023 - 01/2016
6Adenocarcinoma
01/2023 - 12/2006
6Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2022 - 07/2010
6Anemia
10/2022 - 05/2009
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 08/2017
6Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 01/2012
5Insulin Resistance
05/2024 - 01/2014
5Fibrosis (Cirrhosis)
10/2023 - 01/2015
5Acute Liver Failure (Fulminant Hepatic Failure)
09/2023 - 05/2017
5Sepsis (Septicemia)
08/2023 - 01/2019
5Head and Neck Neoplasms (Head and Neck Cancer)
08/2023 - 04/2006
5Body Weight (Weight, Body)
05/2023 - 01/2014
5Hyperglycemia
02/2023 - 01/2017

Drug/Important Bio-Agent (IBA)

35Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2004
28Proteins (Proteins, Gene)FDA Link
05/2024 - 08/2004
22Rituximab (Mabthera)FDA Link
11/2023 - 07/2010
15Glucose (Dextrose)FDA LinkGeneric
10/2023 - 04/2009
14Opioid Analgesics (Opioids)IBA
08/2023 - 08/2014
14Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 07/2005
12Lenalidomide (CC 5013)FDA Link
11/2023 - 07/2012
11CytokinesIBA
05/2023 - 01/2007
10Doxorubicin (Adriamycin)FDA LinkGeneric
12/2023 - 05/2012
10Fluorescent Dyes (Fluorescent Probes)IBA
01/2023 - 01/2018
9LipidsIBA
05/2024 - 01/2017
9Messenger RNA (mRNA)IBA
01/2023 - 11/2004
8Therapeutic UsesIBA
01/2024 - 03/2006
8CholesterolIBA
10/2023 - 02/2012
8DNA (Deoxyribonucleic Acid)IBA
08/2023 - 03/2004
8EnzymesIBA
07/2023 - 04/2005
8Long Noncoding RNAIBA
01/2023 - 08/2011
8ORALIT (ORS)IBA
01/2023 - 07/2008
7RNA (Ribonucleic Acid)IBA
04/2024 - 11/2016
7Peptides (Polypeptides)IBA
11/2023 - 05/2006
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023 - 06/2015
7omega-Chloroacetophenone (Mace)IBA
10/2023 - 01/2018
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2023 - 03/2009
6EscitalopramFDA Link
01/2024 - 01/2019
6PlatinumIBA
01/2024 - 05/2005
6Chimeric Antigen ReceptorsIBA
11/2023 - 01/2020
6LactonesIBA
01/2021 - 01/2017
6TeaIBA
01/2020 - 07/2008
6Bortezomib (Velcade)FDA Link
01/2019 - 02/2016
6Cisplatin (Platino)FDA LinkGeneric
01/2018 - 07/2003
5Reactive Oxygen Species (Oxygen Radicals)IBA
04/2024 - 05/2017
5Interleukin-6 (Interleukin 6)IBA
01/2024 - 01/2007
52'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
10/2023 - 01/2020
5Hemoglobins (Hemoglobin)IBA
10/2023 - 12/2012
5Circular RNAIBA
10/2023 - 01/2022
5DexmedetomidineFDA Link
06/2023 - 04/2015
5Triglycerides (Triacylglycerol)IBA
03/2023 - 02/2012

Therapy/Procedure

109Therapeutics
01/2024 - 07/2002
38Drug Therapy (Chemotherapy)
01/2024 - 06/2006
22Radiotherapy
12/2023 - 06/2006
15Stents
10/2023 - 01/2009
13Thrombectomy
12/2020 - 12/2010
10Percutaneous Coronary Intervention
01/2022 - 08/2017
8Aftercare (After-Treatment)
01/2019 - 06/2007
7Blood Transfusion (Blood Transfusions)
03/2022 - 11/2013
5Artificial Liver (Bioartificial Liver)
09/2023 - 05/2017
5Catheters
03/2023 - 07/2004